State Street’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Sell |
707,687
-7,341
| -1% | -$150K | ﹤0.01% | 2364 |
|
|
2025
Q1 | $14.3M | Buy |
715,028
+4,816
| +0.7% | +$96.4K | ﹤0.01% | 2309 |
|
|
2024
Q4 | $18.9M | Buy |
710,212
+30,211
| +4% | +$805K | ﹤0.01% | 2260 |
|
|
2024
Q3 | $19.4M | Buy |
680,001
+60,924
| +10% | +$1.74M | ﹤0.01% | 2220 |
|
|
2024
Q2 | $13.5M | Buy |
619,077
+13,278
| +2% | +$289K | ﹤0.01% | 2386 |
|
|
2024
Q1 | $13.4M | Buy |
605,799
+25,881
| +4% | +$573K | ﹤0.01% | 2404 |
|
|
2023
Q4 | $12.5M | Buy |
579,918
+14,754
| +3% | +$318K | ﹤0.01% | 2467 |
|
|
2023
Q3 | $9.55M | Buy |
565,164
+29,836
| +6% | +$504K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $7.34M | Buy |
535,328
+12,800
| +2% | +$176K | ﹤0.01% | 2803 |
|
|
2023
Q1 | $11.9M | Buy |
522,528
+18,075
| +4% | +$411K | ﹤0.01% | 2556 |
|
|
2022
Q4 | $11.9M | Buy |
504,453
+6,528
| +1% | +$154K | ﹤0.01% | 2594 |
|
|
2022
Q3 | $13M | Sell |
497,925
-6,599
| -1% | -$172K | ﹤0.01% | 2539 |
|
|
2022
Q2 | $11.1M | Buy |
504,524
+45,819
| +10% | +$1.01M | ﹤0.01% | 2660 |
|
|
2022
Q1 | $20.6M | Buy |
458,705
+2,666
| +0.6% | +$120K | ﹤0.01% | 2377 |
|
|
2021
Q4 | $19.6M | Buy |
456,039
+21,202
| +5% | +$909K | ﹤0.01% | 2494 |
|
|
2021
Q3 | $28.9M | Buy |
434,837
+3,939
| +0.9% | +$262K | ﹤0.01% | 2207 |
|
|
2021
Q2 | $31.6M | Buy |
430,898
+125,419
| +41% | +$9.2M | ﹤0.01% | 2189 |
|
|
2021
Q1 | $20.9M | Buy |
305,479
+44,056
| +17% | +$3.02M | ﹤0.01% | 2348 |
|
|
2020
Q4 | $17.6M | Buy |
261,423
+53,303
| +26% | +$3.58M | ﹤0.01% | 2316 |
|
|
2020
Q3 | $10.7M | Buy |
208,120
+21,262
| +11% | +$1.09M | ﹤0.01% | 2406 |
|
|
2020
Q2 | $7.04M | Buy |
186,858
+36,879
| +25% | +$1.39M | ﹤0.01% | 2588 |
|
|
2020
Q1 | $4.47M | Buy |
149,979
+98,866
| +193% | +$2.95M | ﹤0.01% | 2678 |
|
|
2019
Q4 | $1.76M | Buy |
51,113
+15,091
| +42% | +$519K | ﹤0.01% | 3287 |
|
|
2019
Q3 | $652K | Buy |
+36,022
| New | +$652K | ﹤0.01% | 3467 |
|